Clinical data | |
---|---|
Pronunciation | /bjuːˈpɪvəkeɪn/ |
Trade names | Marcaine, Marcain, Sensorcaine, and Vivacaine |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration |
parenteral, topical |
ATC code | N01BB01 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | 95% |
Metabolism | Liver |
Onset of action | Within 15 min |
Biological half-life | 3.5 hours (adults) 8.1 hours (neonates) |
Duration of action | 2 to 8 hr |
Excretion | Kidney, 4–10% |
Identifiers | |
|
|
CAS Number |
38396-39-3 2180-92-9 |
PubChem (CID) |
2474 CID 5282419 |
IUPHAR/BPS | 2397 |
DrugBank | DB00297 |
ChemSpider | 2380 |
UNII | Y8335394RO |
KEGG | D07552 |
ChEBI | CHEBI:60789 |
ChEMBL | CHEMBL1098 |
ECHA InfoCard | 100.016.867 |
Chemical and physical data | |
Formula | C18H28N2O |
Molar mass | 288.43 g/mol |
3D model (Jmol) | Interactive image |
Melting point | 107 to 108 °C (225 to 226 °F) |
|
|
|
|
(what is this?) |
Bupivacaine, marketed under the brand name Marcaine among others, is a medication used to decrease feeling in a specific area. It is used by injecting it into the area, around a nerve that supplies the area, or into the spinal canal's epidural space. It is available mixed with a small amount of epinephrine to make it last longer. It typically begins working within 15 minutes and lasts for 2 to 8 hours.
Possible side effects include sleepiness, muscle twitching, ringing in the ears, changes in vision, low blood pressure, and an irregular heart rate. Concerns exist that injecting it into a joint can cause problems with the cartilage. Concentrated bupivacaine is not recommended for epidural freezing. Epidural freezing may also increase the length of labor. It is a local anaesthetic of the amide group.
Bupivacaine was discovered in 1957. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Bupivacaine is available as a generic medication and is not very expensive. The wholesale cost in the developing world of a vial is about US$2.10.
Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action. The 0.75% (most concentrated) formulation is used in retrobulbar block. It is the most commonly used local anesthetic in epidural anesthesia during labor, as well as in postoperative pain management.